Mesoblast Limited
Level 1, 843A Glenhuntly Road
Caulfield South
VIC
3162
Tel: 03-9618-7000
305 articles about Mesoblast Limited
-
Mesoblast Limited Announce Positive Results Of Novel Heart Attack Treatment Presented At Premier USA Cardiology Conference
11/16/2010
-
Mesoblast Limited: U.S. Government Grants Awarded for Further Development of Adult Stem Cell Products
11/8/2010
-
Mesoblast Limited Awarded U.S. Government Grants For Further Development of Adult Stem Cell Products
11/8/2010
-
Mesoblast Limited Featured Prominently At International Scientific Conferences
9/20/2010
-
Mesoblast Limited Financial Year End Results: Strong Clinical Progress, Major Regulatory Milestone and Enhanced Corporate Strategy
8/26/2010
-
Mesoblast Limited To Hold Extraordinary General Meeting On The Acquisition Of Angioblast Systems
8/23/2010
-
Mesoblast Limited On Track For Phase 3 Bone Marrow Transplant Trial Following Positive Meeting With United States FDA
8/16/2010
-
Mesoblast Limited Receives Australian Therapeutic Goods Administration Approval To Commercially Manufacture Adult Stem Cell Products
7/21/2010
-
Mesoblast Limited Phase 3 Meeting Scheduled With FDA Following Positive Results Of Bone Marrow Regeneration Trial
7/12/2010
-
United States FDA Clears Mesoblast Limited Phase 2 Trial For Cervical Spinal Fusion
5/19/2010
-
Mesoblast Limited to Acquire Angioblast Systems; Successfully Completes A$37 Million Capital Raise
5/12/2010
-
Mesoblast Limited Market Exclusivity For Its Biologic Products Strengthened By New United States Health Care Act
4/6/2010
-
Mesoblast Limited Key Bone Repair Patent Granted In The United States
3/3/2010
-
Mesoblast Limited National Media Coverage Reported On Positive Preclinical Results For Treatment Of Diabetes
12/21/2009
-
Mesoblast Limited: Single Dose of Proprietary Adult Stem Cells Regenerates Damaged Pancreas and Reduces Blood Glucose Levels in Diabetes
12/18/2009
-
Mesoblast Limited Sustained Six-Month Improvement In Heart Muscle Function With Revascor, "Off-The-Shelf" Adult Stem Cells
11/18/2009
-
Mesoblast Limited Successful Bone Marrow Regeneration In Cancer Patients Using Cord Blood Expanded By Proprietary Stem Cells
11/9/2009
-
Mesoblast Limited Associate Company Angioblast Features At UBS Life Sciences Investor Conference In United States
9/24/2009
-
Mesoblast Limited Enrolment Complete For 2nd Group Of Heart Failure Patients Treated With "Off-The-Shelf" Adult Stem Cells
9/22/2009
-
Mesoblast Limited Disc Repair Results Highlighted At Key Orthopaedic Conference
9/15/2009